Topline results due in Q2 2024 - so April, May or June.
Thankful that another Phase 2 trial has been completed without any Serious Adverse Events.
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial, page-5
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.61 |
Change
-0.150(1.09%) |
Mkt cap ! $1.744B | |||
| Open | High | Low | Value | Volume |
| $13.86 | $13.95 | $13.58 | $798.2K | 57.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 258 | $13.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.60 | 16 | 1 |
View Market Depth
| Last trade - 11.00am 16/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |